Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 211.50
-0.99 (-0.47%)
Sep 11, 2026, 3:29 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 280.94 billion as of September 11, 2026. Its market cap has increased by 6.21% in one year.
Market Cap
280.94B
Enterprise Value
324.51B
Revenue
92.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
211.50
ChartMarket Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 280.94B, an increase of 23.91%. That is a compound annual growth rate of 5.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 280.94B | 22.86% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 499.09B |
| Gland Pharma | 488.19B |
| Ajanta Pharma | 447.18B |
| Emcure Pharmaceuticals | 365.29B |
| Wockhardt | 361.38B |
| Eris Lifesciences | 183.56B |
| Cohance Lifesciences | 172.77B |
| Alivus Life Sciences | 168.40B |